Related references
Note: Only part of the references are listed.Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
Anthony R. Cillo et al.
IMMUNITY (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses
Jesse M. Jaynes et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Immune profiles in primary squamous cell carcinoma of the head and neck
Vassiliki Saloura et al.
ORAL ONCOLOGY (2019)
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma
Axel Lechner et al.
ONCOIMMUNOLOGY (2019)
Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease
Jelani C. Zarif et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl et al.
JCI INSIGHT (2019)
Human Papillomavirus Testing in Head and Neck Carcinomas Guideline From the College of American Pathologists
James S. Lewis et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Diverse Functions of Macrophages in Different Tumor Microenvironments
Ming Yang et al.
CANCER RESEARCH (2018)
Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
Sanja Stevanovic et al.
SCIENCE (2017)
Neutrophils dominate the immune cell composition in non-small cell lung cancer
Julia Kargl et al.
NATURE COMMUNICATIONS (2017)
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa et al.
CELL REPORTS (2017)
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
Pablo Scodeller et al.
SCIENTIFIC REPORTS (2017)
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin A. Kansy et al.
CANCER RESEARCH (2017)
Multiparametric immune profiling in HPV-oral squamous cell cancer
Zipei Feng et al.
JCI INSIGHT (2017)
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
Nghia Nguyen et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors
Oliver Wood et al.
ONCOTARGET (2016)
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
Catherine Sautes-Fridman et al.
FRONTIERS IN IMMUNOLOGY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Prognostic Value of Diametrically Polarized Tumor-Associated Macrophages in Renal Cell Carcinoma
Le Xu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma
Anna M. Wirsing et al.
BMC CLINICAL PATHOLOGY (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Mario Henrique M. Barros et al.
PLOS ONE (2013)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Standardizing immunophenotyping for the Human Immunology Project
Holden T. Maecker et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: Prognostic impact may depend on type of treatment and stage of disease
Luitpold V. Distel et al.
ORAL ONCOLOGY (2009)
Direct multiplexed measurement of gene expression with color-coded probe pairs
Gary K. Geiss et al.
NATURE BIOTECHNOLOGY (2008)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Share Paper
